Eli Lilly cuts cost of certain Zepbound doses by at least 50%

Eli Lilly is expanding the supply of its weight-loss drug and selling it for half the price of other drugs in the highly lucrative market.  Eli Lilly announced on Tuesday that it is now offering 2.5 mg and 5 mg single-dose vials of tirzepatide, sold under the brand name Zepbound, in response to growing demand. In its last fiscal quarter, the company's earnings surpassed Wall Street expectations due in large part because of the performance of Mounjaro and Zepbound, which have the same active ingredient but h ...